Home » EMA Calls for Documentation of Biologic Manufacturing Processes
EMA Calls for Documentation of Biologic Manufacturing Processes
May 10, 2012
Drugmakers seeking approval for biologics trials in the EU must describe and justify their manufacturing processes and process controls, ideally with a flow chart of all steps, the European Medicines Agency (EMA) says.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor